omeprazole has been researched along with Hepatic Veno Occlusive Disease in 1 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The elimination half-life was significantly (p < 0." | 5.32 | Pharmacokinetics of omeprazole in patients with liver cirrhosis and extrahepatic portal venous obstruction. ( Bhargava, VK; Chawla, YK; Dhiman, RK; Dixit, RK; Garg, SK; Kumar, R; Satapathy, SK, 2003) |
| " The elimination half-life was significantly (p < 0." | 1.32 | Pharmacokinetics of omeprazole in patients with liver cirrhosis and extrahepatic portal venous obstruction. ( Bhargava, VK; Chawla, YK; Dhiman, RK; Dixit, RK; Garg, SK; Kumar, R; Satapathy, SK, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, R | 1 |
| Chawla, YK | 1 |
| Garg, SK | 1 |
| Dixit, RK | 1 |
| Satapathy, SK | 1 |
| Dhiman, RK | 1 |
| Bhargava, VK | 1 |
1 other study available for omeprazole and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
Pharmacokinetics of omeprazole in patients with liver cirrhosis and extrahepatic portal venous obstruction.
Topics: Administration, Oral; Adult; Biological Availability; Capsules; Chromatography, High Pressure Liquid | 2003 |